GRI Share Price

GRI Share Price

NASDAQ: GRI | Micro Cap | Healthcare
$1.14
+$1.14 (--%) Last updated on 20 Nov, 2026 | 22:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

GRI Stock Performance

Open
$1.14
Prev. Close
N/A
Circuit Range
N/A
Day Range
$1.14 - $1.14
Year Range
$0.18 - $6.66
Volume
200
Average Traded
$1.14

GRI Share Price Chart

Line chart of the GRI price trend over the selected period. The price rose overall, ranging from 1.14 to 1.14, ending at 1.14.
$1.14$1.14
L
Show Current Price
H

GRI Stock Fundamentals & Key Indicators

Market Cap
$111904.68
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.57
Revenue (TTM)
$0.00
Return On Equity (TTM)
-88.63%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
43.23%

GRI Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.66-$2.00-$1.64-$1.51
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A24.81%18.00%7.93%

GRI Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$13.04-$10.12-$11.96
Net Profit MarginN/AN/AN/A
Income ChangeN/A22.39%-18.18%

GRI Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets0.070.120.02
Current Assets8.595.622.93
Total Assets8.675.742.96
Non Current Liabilities0.020.070.0
Current Liabilities2.641.642.7
Total Liabilities2.661.712.7
Shareholders' Equity6.014.030.26

GRI Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-10.19-8.61-8.99
Investing0.00.0-0.01
Financing13.3911.8310.8

Corporate Actions

Split
Ex-date: 26 Jan 2026

Split
Ex-date: 24 Feb 2025

Split
Ex-date: 18 Jun 2024

Split
Ex-date: 30 Jan 2024

Dividend
Ex-date: 19 Dec 2019

Dividend
Ex-date: 19 Sep 2019

Dividend
Ex-date: 20 Jun 2019

Dividend
Ex-date: 21 Mar 2019

Dividend
Ex-date: 20 Dec 2018

Dividend
Ex-date: 20 Sep 2018

Dividend
Ex-date: 21 Jun 2018

About GRI

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

GRI Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.56
$1.14
-26.45%
Oct 2026
$1.96
$1.55
-27.91%
Sep 2026
$1.94
$2.15
+2.87%
Aug 2026
$1.45
$2.09
+46.15%
Jul 2026
$1.83
$1.43
-20.99%
Jun 2026
$2.03
$1.81
-12.14%
May 2026
$2.23
$2.06
-8.04%
Apr 2026
$2.39
$2.24
+0.90%
Mar 2026
$2.42
$2.22
-12.94%
Feb 2026
$3.13
$2.55
-21.66%
Jan 2026
$0.24
$3.25
+1,239.51%
Dec 2025
$1.97
$0.24
-87.85%

GRI Share Price FAQs